Your browser doesn't support javascript.
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic. / Infección grave por coronavirus SARS-CoV-2: experiencia en un hospital de tercer nivel con pacientes afectados por COVID-19 durante la pandemia 2020.
Rodríguez, A; Moreno, G; Gómez, J; Carbonell, R; Picó-Plana, E; Benavent Bofill, C; Sánchez Parrilla, R; Trefler, S; Esteve Pitarch, E; Canadell, L; Teixido, X; Claverias, L; Bodí, M.
  • Rodríguez A; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España; URV/IIPSV/CIBERES, España. Electronic address: ahr1161@yahoo.es.
  • Moreno G; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Gómez J; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España; UCI23 Data análisis/URV/IISPV.
  • Carbonell R; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Picó-Plana E; Servicio de Microbiología Clínica, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Benavent Bofill C; Laboratorio Central Área de Biología Molecular, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Sánchez Parrilla R; Laboratorio Central Urgencias, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Trefler S; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Esteve Pitarch E; Servicio de Farmacia Clínica, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Canadell L; Servicio de Farmacia Clínica, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Teixido X; Departamento de Enfermería, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Claverias L; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España.
  • Bodí M; Servicio de Medicina Intensiva, Hospital Universitari de Tarragona Joan XXIII, Tarragona, España; URV/IIPSV/CIBERES, España.
Med Intensiva (Engl Ed) ; 44(9): 525-533, 2020 Dec.
Article in English, Spanish | MEDLINE | ID: covidwho-644103
ABSTRACT

OBJECTIVE:

To describe the clinical and respiratory characteristics of a cohort of 43 patients with COVID-19 after an evolutive period of 28 days.

DESIGN:

A prospective, single-center observational study was carried out.

SETTING:

Intensive care. PATIENTS Patients admitted due to COVID-19 and respiratory failure.

INTERVENTIONS:

None. VARIABLES Automatic recording was made of demographic variables, severity parameters, laboratory data, assisted ventilation (HFO high-flow oxygen therapy and IMV invasive mechanical ventilation), oxygenation (PaO2, PaO2/FiO2) and complications. The patients were divided into three groups survivors (G1), deceased (G2) and patients remaining under admission (G3). The chi-squared test or Fisher exact test (categorical variables) was used, along with the Mann-Whitney U-test or Wilcoxon test for analyzing the differences between medians. Statistical significance was considered for p<0.05.

RESULTS:

A total of 43 patients were included (G1=28 [65.1%]; G2=10 [23.3%] and G3=5 [11.6%]), with a mean age of 65 years (range 52-72), 62% males, APACHE II 18 (15-24), SOFA 6 (4-7). Arterial hypertension (30.2%) and obesity (25.6%) were the most frequent comorbidities. High-flow oxygen therapy was used in 62.7% of the patients, with failure in 85%. In turn, 95% of the patients required IMV and 85% received ventilation in prone decubitus. In the general population, initial PaO2/FiO2 improved after 7 days (165 [125-210] vs.194 [153-285]; p=0.02), in the same way as in G1 (164 [125-197] vs. 207 [160-294]; p=0.07), but not in G2 (163 [95-197] vs. 135 [85-177]). No bacterial coinfection was observed. The incidence of IMV-associated pneumonia was high (13 episodes/1000 days of IMV).

CONCLUSIONS:

Patients with COVID-19 require early IMV, a high frequency of ventilation in prone decubitus, and have a high incidence of failed HFO. The lack of improvement of PaO2/FiO2 at 7 days could be a prognostic marker. .
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English / Spanish Journal: Med Intensiva (Engl Ed) Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English / Spanish Journal: Med Intensiva (Engl Ed) Year: 2020 Document Type: Article